Sunday, September 30, 2018

Dr Reddy#39;s Labs terminates Armis Biopharma#39;s licence for its investigational antibacterial product

Dr Reddy#39;s Labs terminates Armis Biopharma#39;s licence for its investigational antibacterial product According to a press release issued by the Indian drug maker, as a result of the termination, Dr Reddy#39;s has regained worldwide rights to DFA-02, and is currently evaluating its options to take the programme forward.

from Moneycontrol Business News https://ift.tt/2Iutlyu
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Vikas Khemani on key triggers that will shape the market’s next big move

Most people kind of turned bearish on global concerns, oil prices. So, people tend to kind of extrapolate more bad news. So that has happene...